Barclays Issues Positive Forecast for Encompass Health (NYSE:EHC) Stock Price

Encompass Health (NYSE:EHC) had its price target lifted by Barclays from $116.00 to $118.00 in a research note published on Friday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock.

Other research analysts have also recently issued reports about the stock. KeyCorp raised their target price on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a report on Friday. Royal Bank of Canada increased their target price on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. Finally, Truist Financial reaffirmed a “buy” rating and set a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. One equities research analyst has rated the stock with a hold rating, nine have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $107.33.

Encompass Health Stock Up 1.3 %

Shares of EHC opened at $99.86 on Friday. The firm has a market cap of $10.06 billion, a P/E ratio of 22.39, a price-to-earnings-growth ratio of 1.18 and a beta of 0.90. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. Encompass Health has a 52 week low of $72.37 and a 52 week high of $104.55. The firm’s 50-day simple moving average is $96.28 and its 200 day simple moving average is $95.30.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.17 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%. On average, analysts forecast that Encompass Health will post 4.76 earnings per share for the current year.

Institutional Investors Weigh In On Encompass Health

Hedge funds and other institutional investors have recently modified their holdings of the company. TD Private Client Wealth LLC increased its stake in Encompass Health by 2,870.0% during the 3rd quarter. TD Private Client Wealth LLC now owns 7,336 shares of the company’s stock valued at $709,000 after purchasing an additional 7,089 shares in the last quarter. Los Angeles Capital Management LLC grew its holdings in shares of Encompass Health by 532.4% during the third quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock valued at $4,860,000 after buying an additional 42,338 shares during the last quarter. Pathstone Holdings LLC increased its position in shares of Encompass Health by 54.5% during the third quarter. Pathstone Holdings LLC now owns 21,022 shares of the company’s stock worth $2,032,000 after acquiring an additional 7,412 shares in the last quarter. Meeder Asset Management Inc. raised its holdings in shares of Encompass Health by 43.8% in the 3rd quarter. Meeder Asset Management Inc. now owns 66,405 shares of the company’s stock worth $6,417,000 after acquiring an additional 20,242 shares during the last quarter. Finally, Geode Capital Management LLC lifted its position in Encompass Health by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock valued at $161,781,000 after acquiring an additional 20,547 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.